Effects of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) on Pharmacokinetic Parameters of Rosiglitazone in Healthy Subjects

BACKGROUND: Icosapent ethyl is a high-purity form of eicosapentaenoic acid ethyl ester approved to reduce triglyceride levels in adults with triglycerides ≥500 mg/dL. Candidates for triglyceride-lowering therapy include patients with diabetes mellitus who may be receiving rosiglitazone. We assessed...

Descripción completa

Detalles Bibliográficos
Autores principales: Braeckman, Rene A, Stirtan, William G, Soni, Paresh N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467261/
https://www.ncbi.nlm.nih.gov/pubmed/26097794
http://dx.doi.org/10.1002/cpdd.150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467261/
https://www.ncbi.nlm.nih.gov/pubmed/26097794
http://dx.doi.org/10.1002/cpdd.150

Ejemplares similares